J&J to acquire Rhinocort Aqua outside the US

11 October 2016 - Deborah Wilkes

Archived

Johnson & Johnson is set to acquire the rights to AstraZeneca's Rhinocort Aqua nasal spray outside the US in a deal worth US$330 million.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: